The University of Chicago Header Logo

Connection

Siri Atma W. Greeley to Humans

This is a "connection" page, showing publications Siri Atma W. Greeley has written about Humans.
Connection Strength

0.748
  1. ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2022 12; 23(8):1188-1211.
    View in: PubMed
    Score: 0.029
  2. Growth and development in monogenic forms of neonatal diabetes. Curr Opin Endocrinol Diabetes Obes. 2022 02 01; 29(1):65-77.
    View in: PubMed
    Score: 0.028
  3. Precision Medicine: Long-Term Treatment with Sulfonylureas in Patients with Neonatal Diabetes Due to KCNJ11 Mutations. Curr Diab Rep. 2019 06 27; 19(8):52.
    View in: PubMed
    Score: 0.023
  4. Monogenic diabetes: the impact of making the right diagnosis. Curr Opin Pediatr. 2018 08; 30(4):558-567.
    View in: PubMed
    Score: 0.022
  5. Congenital Diabetes: Comprehensive Genetic Testing Allows for Improved Diagnosis and Treatment of Diabetes and Other Associated Features. Curr Diab Rep. 2018 06 13; 18(7):46.
    View in: PubMed
    Score: 0.022
  6. Precision medicine in KCNJ11 permanent neonatal diabetes. Lancet Diabetes Endocrinol. 2018 08; 6(8):594-595.
    View in: PubMed
    Score: 0.022
  7. Congenital forms of diabetes: the beta-cell and beyond. Curr Opin Genet Dev. 2018 06; 50:25-34.
    View in: PubMed
    Score: 0.021
  8. Pancreatic Histopathology of Human Monogenic Diabetes Due to Causal Variants in KCNJ11, HNF1A, GATA6, and LMNA. J Clin Endocrinol Metab. 2018 01 01; 103(1):35-45.
    View in: PubMed
    Score: 0.021
  9. Neonatal Diabetes Mellitus: An Update on Diagnosis and Management. Clin Perinatol. 2018 03; 45(1):41-59.
    View in: PubMed
    Score: 0.021
  10. Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures. Pediatr Diabetes. 2018 05; 19(3):393-397.
    View in: PubMed
    Score: 0.021
  11. The Effect of the Testis on the Ovary: Structure-Function Relationships in a Neonate with a Unilateral Ovotestis (Ovotesticular Disorder of Sex Development)?. Horm Res Paediatr. 2017; 87(3):205-212.
    View in: PubMed
    Score: 0.020
  12. Preservation of Reduced Numbers of Insulin-Positive Cells in Sulfonylurea-Unresponsive KCNJ11-Related Diabetes. J Clin Endocrinol Metab. 2017 01 01; 102(1):1-5.
    View in: PubMed
    Score: 0.020
  13. Extremely Early Onset IPEX Syndrome Caused by a Novel Small Exonic Deletion in FOXP3. J Pediatr Gastroenterol Nutr. 2016 11; 63(5):e119-e120.
    View in: PubMed
    Score: 0.019
  14. Patients with KCNJ11-related diabetes frequently have neuropsychological impairments compared with sibling controls. Diabet Med. 2016 10; 33(10):1380-6.
    View in: PubMed
    Score: 0.019
  15. Successful rhIGF1 treatment for over 5 years in a patient with severe insulin resistance due to homozygous insulin receptor mutation. Diabet Med. 2016 Mar; 33(3):e8-e12.
    View in: PubMed
    Score: 0.018
  16. An online monogenic diabetes discussion group: supporting families and fueling new research. Transl Res. 2015 Nov; 166(5):425-31.
    View in: PubMed
    Score: 0.018
  17. Continued lessons from the INS gene: an intronic mutation causing diabetes through a novel mechanism. J Med Genet. 2015 Sep; 52(9):612-6.
    View in: PubMed
    Score: 0.018
  18. Response letter to the editor. J Clin Endocrinol Metab. 2015 Jan; 100(1):L14.
    View in: PubMed
    Score: 0.017
  19. Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons. J Clin Endocrinol Metab. 2014 Dec; 99(12):E2709-14.
    View in: PubMed
    Score: 0.017
  20. Hyperinsulinism in a neonate. Pediatr Ann. 2014 Mar; 43(3):e56-60.
    View in: PubMed
    Score: 0.016
  21. Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation. Diabetes Care. 2013 Dec; 36(12):e201.
    View in: PubMed
    Score: 0.016
  22. Microcephaly, epilepsy, and neonatal diabetes due to compound heterozygous mutations in IER3IP1: insights into the natural history of a rare disorder. Pediatr Diabetes. 2014 May; 15(3):252-6.
    View in: PubMed
    Score: 0.016
  23. Neonatal diabetes, gallbladder agenesis, duodenal atresia, and intestinal malrotation caused by a novel homozygous mutation in RFX6. Pediatr Diabetes. 2014 Feb; 15(1):67-72.
    View in: PubMed
    Score: 0.015
  24. Genomic sequencing in newborn screening programs. JAMA. 2012 May 23; 307(20):2146-7; author reply 2147.
    View in: PubMed
    Score: 0.014
  25. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Curr Diab Rep. 2011 Dec; 11(6):519-32.
    View in: PubMed
    Score: 0.014
  26. Creation of the Web-based University of Chicago Monogenic Diabetes Registry: using technology to facilitate longitudinal study of rare subtypes of diabetes. J Diabetes Sci Technol. 2011 Jul 01; 5(4):879-86.
    View in: PubMed
    Score: 0.013
  27. The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. Diabetes Care. 2011 Mar; 34(3):622-7.
    View in: PubMed
    Score: 0.013
  28. Neonatal diabetes mellitus: a model for personalized medicine. Trends Endocrinol Metab. 2010 Aug; 21(8):464-72.
    View in: PubMed
    Score: 0.012
  29. Update in neonatal diabetes. Curr Opin Endocrinol Diabetes Obes. 2010 Feb; 17(1):13-9.
    View in: PubMed
    Score: 0.012
  30. Diagnosis and treatment of neonatal diabetes: a United States experience. Pediatr Diabetes. 2008 Oct; 9(5):450-9.
    View in: PubMed
    Score: 0.011
  31. Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes. Diabetes Care. 2024 Mar 01; 47(3):393-400.
    View in: PubMed
    Score: 0.008
  32. A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life. Diabetologia. 2024 May; 67(5):940-951.
    View in: PubMed
    Score: 0.008
  33. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nat Med. 2023 Oct; 29(10):2438-2457.
    View in: PubMed
    Score: 0.008
  34. Insulin Deficiency From Insulin Gene Mutation Leads to Smaller Pancreas. Diabetes Care. 2023 04 01; 46(4):773-776.
    View in: PubMed
    Score: 0.008
  35. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med. 2002 Apr; 8(4):399-402.
    View in: PubMed
    Score: 0.007
  36. Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes. Sci Rep. 2021 11 03; 11(1):21590.
    View in: PubMed
    Score: 0.007
  37. Development of a standardized MRI protocol for pancreas assessment in humans. PLoS One. 2021; 16(8):e0256029.
    View in: PubMed
    Score: 0.007
  38. The Do-It-Yourself Artificial Pancreas. Pediatr Ann. 2021 Jul; 50(7):e304-e307.
    View in: PubMed
    Score: 0.007
  39. Novel compound heterozygous LRBA deletions in a 6-month-old with neonatal diabetes. Diabetes Res Clin Pract. 2021 May; 175:108798.
    View in: PubMed
    Score: 0.007
  40. Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care. 2020 12; 43(12):3117-3128.
    View in: PubMed
    Score: 0.006
  41. Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes. Diabetes Care. 2021 01; 44(1):35-42.
    View in: PubMed
    Score: 0.006
  42. Using a Do-It-Yourself Artificial Pancreas: Perspectives from Patients and Diabetes Providers. J Diabetes Sci Technol. 2020 09; 14(5):860-867.
    View in: PubMed
    Score: 0.006
  43. A Non-Coding Disease Modifier of Pancreatic Agenesis Identified by Genetic Correction in a Patient-Derived iPSC Line. Cell Stem Cell. 2020 07 02; 27(1):137-146.e6.
    View in: PubMed
    Score: 0.006
  44. Update of variants identified in the pancreatic ß-cell KATP channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes. Hum Mutat. 2020 05; 41(5):884-905.
    View in: PubMed
    Score: 0.006
  45. Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2). Diabetes. 2019 08; 68(8):1565-1576.
    View in: PubMed
    Score: 0.006
  46. GCK-MODY in the US Monogenic Diabetes Registry: Description of 27 unpublished variants. Diabetes Res Clin Pract. 2019 May; 151:231-236.
    View in: PubMed
    Score: 0.006
  47. Trisomy 21 Is a Cause of Permanent Neonatal Diabetes That Is Autoimmune but Not HLA Associated. Diabetes. 2019 07; 68(7):1528-1535.
    View in: PubMed
    Score: 0.006
  48. Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry. Acta Diabetol. 2019 Apr; 56(4):405-411.
    View in: PubMed
    Score: 0.006
  49. ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2018 10; 19 Suppl 27:47-63.
    View in: PubMed
    Score: 0.006
  50. Reprogramming human T cell function and specificity with non-viral genome targeting. Nature. 2018 07; 559(7714):405-409.
    View in: PubMed
    Score: 0.005
  51. Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 9 affected individuals. Genet Med. 2019 01; 21(1):233-242.
    View in: PubMed
    Score: 0.005
  52. FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Diabetes. 2018 05; 19(3):388-392.
    View in: PubMed
    Score: 0.005
  53. ADHD, learning difficulties and sleep disturbances associated with KCNJ11-related neonatal diabetes. Pediatr Diabetes. 2017 Nov; 18(7):518-523.
    View in: PubMed
    Score: 0.005
  54. GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated. Acta Diabetol. 2016 Oct; 53(5):703-8.
    View in: PubMed
    Score: 0.005
  55. Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes. Diabetologia. 2015 Jul; 58(7):1430-5.
    View in: PubMed
    Score: 0.004
  56. Commentary: Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype. J Clin Endocrinol Metab. 2015 Apr; 100(4):1234-6.
    View in: PubMed
    Score: 0.004
  57. Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach. Mol Genet Metab. 2014 Dec; 113(4):315-320.
    View in: PubMed
    Score: 0.004
  58. Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care. 2014; 37(1):202-9.
    View in: PubMed
    Score: 0.004
  59. Gain-of-function mutations in the K(ATP) channel (KCNJ11) impair coordinated hand-eye tracking. PLoS One. 2013; 8(4):e62646.
    View in: PubMed
    Score: 0.004
  60. Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype. Diabetologia. 2013 Jan; 56(1):218-21.
    View in: PubMed
    Score: 0.004
  61. Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas. Diabetes Care. 2012 Oct; 35(10):2086-8.
    View in: PubMed
    Score: 0.004
  62. Onset features and subsequent clinical evolution of childhood diabetes over several years. Pediatr Diabetes. 2011 Jun; 12(4 Pt 1):326-34.
    View in: PubMed
    Score: 0.003
  63. HLA-DQ haplotypes differ by ethnicity in patients with childhood-onset diabetes. Pediatr Diabetes. 2011 Jun; 12(4 Pt 2):388-95.
    View in: PubMed
    Score: 0.003
  64. Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect. Diabetes Care. 2009 Aug; 32(8):1428-30.
    View in: PubMed
    Score: 0.003
  65. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A. 2007 Sep 18; 104(38):15040-4.
    View in: PubMed
    Score: 0.003
  66. Educating future leaders of medical research: analysis of student opinions and goals from the MD-PhD SAGE (Students' Attitudes, Goals, and Education) survey. Acad Med. 2007 Jul; 82(7):633-45.
    View in: PubMed
    Score: 0.003
  67. Educational views and attitudes, and career goals of MD-PhD students at the University of Pennsylvania School of Medicine. Acad Med. 2005 Feb; 80(2):193-8.
    View in: PubMed
    Score: 0.002
  68. MD-PhD students in a major training program show strong interest in becoming surgeon-scientists. Clin Orthop Relat Res. 2004 Aug; (425):258-63.
    View in: PubMed
    Score: 0.002
  69. The role of t/b lymphocyte collaboration in the regulation of autoimmune and alloimmune responses. Immunol Res. 2003; 27(2-3):443-50.
    View in: PubMed
    Score: 0.002
  70. B-cell deficiency and type 1 diabetes. N Engl J Med. 2002 Feb 14; 346(7):538-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.